Delta Oil & Gas : Appoints Jordan P. Balencic, D.O. As Chief Compliance Officer

Delta Oil & Gas Appoints Jordan P. Balencic, D.O. As Chief Compliance Officer

July 20, 2018 - Delta Oil & Gas, Inc. (the 'Company') (OTC: DLTA), is pleased to announce that it has appointed Dr. Jordan Balencic, D.O. to the Company as Chief Compliance Officer. Dr. Balencic has a long history over 10 years of equity investments, public company accounting and compliance, mergers & acquisitions and market strategy.

This appointment was completed to support the Company in the execution of its business plan by initially launching a turn-around plan to include completing the Company's audits, state filings, and SECfilings to regain compliance as a fully reporting OTCQBCompany.

Dr. Balencic's initial focus will be to support management in becoming fully compliant again while executing planned acquisitions already being evaluated and negotiated with to begin expansion of the Company's portfolio.

'This is a unique time for Delta as oil prices have reached 4 year highs and the market is ripe for acquisitions of production with development potential and operating oilfield businesses. I am pleased to join Delta at this time to re-energize its current portfolio, regain compliance status and position for a merger & acquisition program,' stated Chief Compliance Officer Jordan Balencic, D.O..

About Delta Oil & Gas, Inc.

Delta Oil & Gas, Inc. (OTC:DLTA) is an energy holding company which targets projects or businesses that are of extremely high quality, low to medium risk and close to hydrocarbon delivery points. The Company operates exclusively within North America. We currently hold substantial land positions with varying Working Interests in a number of California regional plays, Texas and Oklahoma with a focus on larger and much higher impact targets in the USAof both conventional oil and gas reserves.
About Jordan P. Balencic, D.O.

Dr. Balencic, is a physician of Internal Medicine and successful entrepreneur. He currently serves the U.S Department of Veterans Affairs as a Primary Care Physician. Dr. Balencic is a Professional Fellow for the Social Enterprise Institute at Elizabethtown College where he mentors emerging startup founders and social entrepreneurs on healthcare innovation and lean startup methodology. He has extensive consulting and healthcare advisory experience for both private and public companies. Dr. Balencic is also on the Board of Directors of True Nature Holding, Inc. (QTCQB: TNTY), a company pursuing a roll-up of businesses in the compounding pharmacy industry. Dr. Balencic completed his Internal Medicine Residency training at Pennsylvania State University, obtained his Medical Doctoral degree at Lake Erie College of Osteopathic Medicine, and has a Bachelor of Science in Biology from Gannon University.

Forward-Looking Statements This press release contains forward-looking statements that involve risks, uncertainties and assumptions that could cause our results to differ materially from those expressed or implied by such forward-looking statements. All statements, other than statements of historical fact, are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, any statements regarding our strategy; any statements regarding visibility and future utilization; any projections of financial items; any statements regarding future operations expenditures; any statements regarding the plans, strategies and objectives of management for future operations; any statements regarding our ability to enter into and/or perform commercial contracts; any statements concerning developments; any statements regarding future economic conditions or performance; any statements regarding the offering and the use of proceeds therefrom; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. The forward-looking statements are subject to a number of known and unknown risks, uncertainties and other factors that could cause results to differ materially from those in the forward-looking statements, including but not limited to the results of the repurchase offer; market conditions; the performance of contracts by suppliers, customers and partners; actions by governmental and regulatory authorities; operating hazards and delays, which includes delays in delivery, chartering or customer acceptance of assets or terms of their acceptance; our ultimate ability to realize current backlog; employee management issues; complexities of global political and economic developments; geologic risks; volatility of oil and gas prices and other risks described from time to time in our reports filed with the SEC, including DLTA's most recently filed Annual Report on Form 10-K and in DLTA's other filings with the SEC, which are available free of charge on the SEC's website at www.sec.gov. We assume no obligation and do not intend to update these forward-looking statements except as required by the securities laws.

OTCMarkets Profile: https://www.otcmarkets.com/stock/DLTA/overview

Contact:

Delta Oil & Gas, Inc.

700 West Pender Street Suite 304

Vancouver, BCCanada V6C1G8

Email: ir@deltaoilandgas.com

Website: http://www.deltaoilandgas.com